-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.
-
Summary
-
Cocrystal Pharma, Inc. quarterly/annual Net Cash Provided by (Used in) Operating Activities history and growth rate from 2012 to 2023.
- Cocrystal Pharma, Inc. Net Cash Provided by (Used in) Operating Activities for the quarter ending March 31, 2024 was -$4.5M, a 44.7% decline year-over-year.
- Cocrystal Pharma, Inc. annual Net Cash Provided by (Used in) Operating Activities for 2023 was -$14.7M, a 31.6% increase from 2022.
- Cocrystal Pharma, Inc. annual Net Cash Provided by (Used in) Operating Activities for 2022 was -$21.4M, a 68.5% decline from 2021.
- Cocrystal Pharma, Inc. annual Net Cash Provided by (Used in) Operating Activities for 2021 was -$12.7M, a 29.4% decline from 2020.
Net Cash Provided by (Used in) Operating Activities, Trailing 12 Months (USD)
Net Cash Provided by (Used in) Operating Activities, Annual (USD)
Net Cash Provided by (Used in) Operating Activities, YoY Annual Growth (%)